Drug Chatter -- Tracking biopharma stock chatter

Profile for BioMarin Pharmaceutical Inc. (BMRN)

« Back to company index

BMRN Chatter Timeline

Stock Ticker for BMRN

Most Active Tweeters for BMRN

UserTweets
@Socalsurfer3 24
@Gupta_Calling 12
@dispatchtribune 9
@AmericanBanking 9
@WatchlistN 9

Recent Tweets for BMRN

BioWorld @BioWorld
$BMRN aces final exam: Palynziq gains FDA approval to treat PKU in adults https://t.co/5l28RmPxjt
May 25th 2018, 10:05pm
WatchlistN @WatchlistN
BioMarin Pharmaceutical $BMRN Shares Gap Up on Analyst Upgrade https://t.co/PPs7VFdEuw
May 25th 2018, 7:05pm
IBD_AGatlin @IBD_AGatlin
BioMarin's new rare-disease drug costs more than expected $BMRN https://t.co/Sah1zGJ39U
May 25th 2018, 5:05pm
dakotafinancial @dakotafinancial
Wedbush Reiterates Outperform Rating for BioMarin Pharmaceutical $BMRN https://t.co/khnZ3Fz8ix
May 25th 2018, 4:05pm
registrarjourn @registrarjourn
Wedbush Reiterates Outperform Rating for BioMarin Pharmaceutical $BMRN https://t.co/82ro8RCLvU
May 25th 2018, 4:05pm
WeekHerald @WeekHerald
Credit Suisse Group Boosts BioMarin Pharmaceutical $BMRN Price Target to $120.00 https://t.co/HyzcqL6ZcE
May 25th 2018, 2:05pm
WatchlistN @WatchlistN
Credit Suisse Group Boosts BioMarin Pharmaceutical $BMRN Price Target to $120.00 https://t.co/8OPLf6MIRN
May 25th 2018, 2:05pm
TickerReport @TickerReport
Credit Suisse Group Boosts BioMarin Pharmaceutical $BMRN Price Target to $120.00 https://t.co/U9cjyL3jd4
May 25th 2018, 2:05pm
SeekingAlpha @SeekingAlpha
$BMRN https://t.co/mSofZVXFdZ
May 25th 2018, 1:05pm
SA_BioTech @SA_BioTech
$BMRN https://t.co/yV9UEgN92M
May 25th 2018, 1:05pm
ledgerzette @ledgerzette
BioMarin Pharmaceutical $BMRN Receives Consensus Rating of “Buy” from Analysts https://t.co/lm7FABANLl
May 25th 2018, 1:05pm
StockNewsWires @StockNewsWires
$BMRN: BioMarin’s New Rare-Disease Med Costs 50% More Than Expected: https://t.co/WiyLmqNqZo
May 25th 2018, 12:05pm
BioPharmaDive @BioPharmaDive
$BMRN cleared to bring new PKU drug to market https://t.co/IwJmDmPeRi
May 25th 2018, 12:05pm
AnalystWire @AnalystWire
BioMarin Pharmaceutical Inc. $BMRN PT Lowered to $121 at SunTrust https://t.co/dZd5TaOdOV
May 25th 2018, 12:05pm
Gupta_Calling @Gupta_Calling
$BMRN to "sustainably high EPS", expecting shares to move "measurably" higher in the coming quarters. Read more at… https://t.co/6Iv4VMHwVW
May 25th 2018, 11:05am
Gupta_Calling @Gupta_Calling
$bmrn TP $114 PIPER BioMarin analyst commentary at Piper Jaffray BioMarin approval of Palynziq is good news, says… https://t.co/AZOpEOocGm
May 25th 2018, 11:05am
Gupta_Calling @Gupta_Calling
$BMRN treatment of PKU a day before PDUFA. The analyst adds that while the approval was expected, better labeling a… https://t.co/KojSNHkbgj
May 25th 2018, 11:05am
Gupta_Calling @Gupta_Calling
$bmrn BioMarin (BMRN) PT Raised to $120 at Oppenheimer; 'Adds a seventh commercial product' https://t.co/ZmpUM7ADaz
May 25th 2018, 11:05am
Gupta_Calling @Gupta_Calling
$BMRN Analyst Michael Ulz commented, "The FDA approved Palynziq (pegvaliase-pqpz) for the treatment of adult patien… https://t.co/sVmF49wTbW
May 25th 2018, 11:05am
Gupta_Calling @Gupta_Calling
$BMRN launch at the end of June, while pricing was in line with prior guidance ($192K/yr). Overall, we are encourag… https://t.co/YerDNcoiXN
May 25th 2018, 11:05am
Gupta_Calling @Gupta_Calling
$bmrn UPDATE: BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $146 at Leerink Partners, Just Behind Cowen's Street… https://t.co/PbRsZPTF9r
May 25th 2018, 11:05am
Gupta_Calling @Gupta_Calling
$BMRN commercialization efforts and adjusts his model estimates which drive the PT higher.
May 25th 2018, 11:05am
signalsfinancia @signalsfinancia
$BMRN | Take Profits 1/2 #daytrading #stocks #finance https://t.co/53cYFnZ3Ck
May 25th 2018, 11:05am
ArmengolRivera @ArmengolRivera
$BMRN So you wanna go or not? Dont really like BIO Crazy moves.
May 25th 2018, 11:05am
pnani456 @pnani456
$BMRN D1 bull flag breakout / W1 outside week https://t.co/49CPAoWPeb
May 25th 2018, 10:05am
SFBIZronleuty @SFBIZronleuty
There are lots of questions about $BMRN's new #PKU drug, but 2 things are pretty sure: It will cost more and it wil… https://t.co/ykpn0R5MtS
May 25th 2018, 10:05am
biotechday @biotechday
There are lots of questions about $BMRN's new #PKU drug, but 2 things are pretty sure: It will cost more and it wil… https://t.co/g8apX02lIw
May 25th 2018, 10:05am
rleuty_biotech @rleuty_biotech
There are lots of questions about $BMRN's new #PKU drug, but 2 things are pretty sure: It will cost more and it wil… https://t.co/fVWYdQgJVl
May 25th 2018, 10:05am
victoriouscake @victoriouscake
Part of the positive market reaction to $BMRN getting FDA approval of Palynziq (pegvaliase) is bc of the level of d… https://t.co/CF24dhwO4K
May 25th 2018, 10:05am
signalsfinancia @signalsfinancia
$BMRN | NEW ENTRY SIGNAL https://t.co/ESk64Ikn4q | Click to See https://t.co/8ivsduqS7k
May 25th 2018, 9:05am
whotrades @whotrades
BioMarin shares rise on FDA approval of rare metabolic disorder drug $BMRN https://t.co/N2kBcqBzRq
May 25th 2018, 9:05am
sleekoptions @sleekoptions
$BMRN ft_body_gt_10sma_daily Stock at: 91.36 Open Jul-20 95 Calls at $4 per contract. https://t.co/EQaWPSunZu
May 25th 2018, 9:05am
sleekoptions @sleekoptions
$BMRN sma3x10_call Stock at: 91.36 Open Jul-20 95 Calls at $4 per contract. https://t.co/OLj4UTPTXs
May 25th 2018, 9:05am
BioWorld @BioWorld
After Thursday's market close: $BMRN aces Palynziq as first enzyme therapy to treat PKU https://t.co/EymscAJMwz
May 25th 2018, 9:05am
SwingTradeBot @SwingTradeBot
Recent $BMRN technical alerts: Calm After Storm plus 11 more alerts... https://t.co/Z4Rf60nIDP
May 25th 2018, 9:05am
CNAFinance @CNAFinance
$BMRN heads for the top on FDA approval. Here's what you need to know! https://t.co/qtTpqexzrl
May 25th 2018, 8:05am
dispatchtribune @dispatchtribune
Canaccord Genuity Increases BioMarin Pharmaceutical $BMRN Price Target to $105.00 https://t.co/vNXShDq4Xe
May 25th 2018, 8:05am
Socalsurfer3 @Socalsurfer3
$bmrn REMS initial dosing protocol for Palynziq is MUCH easier than that of clinical trials where patient would nee… https://t.co/3itjUzwSCD
May 25th 2018, 8:05am
Hypocrites_Oath @Hypocrites_Oath
RT @OpenOutcrier: $BMRN (+2.7% pre) BioMarin shares rise on FDA approval of rare metabolic disorder drug - MW https://t.co/ElkeS44ila
May 25th 2018, 8:05am
OpenOutcrier @OpenOutcrier
$BMRN (+2.7% pre) BioMarin shares rise on FDA approval of rare metabolic disorder drug - MW https://t.co/ElkeS44ila
May 25th 2018, 8:05am
govermentchild @govermentchild
$bmrn BioMarin Pharma (BMRN) Receives Standard Approval for Palynziq Injection for Treatment of Adults with Phenylketonuria
May 25th 2018, 7:05am
Lay_Summaries @Lay_Summaries
RT @fwpharma: BioMarin's Palynziq garners FDA approval for adults with phenylketonuria https://t.co/JcemD3rmFN $BMRN
May 25th 2018, 7:05am
Socalsurfer3 @Socalsurfer3
$bmrn Credit Suisse reiterates Outperform, raises PT to $120
May 25th 2018, 7:05am
evaluatepharma @evaluatepharma
RT @EPVantage: Vantage Snippet - Biomarin expects slow start for Kuvan’s successor $BMRN https://t.co/4ziD7SFJZm
May 25th 2018, 7:05am
EPVantage @EPVantage
Vantage Snippet - Biomarin expects slow start for Kuvan’s successor $BMRN https://t.co/4ziD7SFJZm
May 25th 2018, 6:05am
ledgerzette @ledgerzette
ValuEngine Lowers BioMarin Pharmaceutical $BMRN to Sell https://t.co/sxkDFkhE8x
May 25th 2018, 6:05am
pnani456 @pnani456
RT @AnalystWire: BioMarin Pharmaceutical Inc. $BMRN PT Raised to $98 at RBC Capital https://t.co/sDRiKS3oZD
May 25th 2018, 6:05am
biostockfan @biostockfan
RT @BioBreakout: $BMRN BioMarin Pharma Receives FDA Approval for Palynziq Injection for Treatment of Adults with Phenylketonuria
May 25th 2018, 6:05am
AnalystWire @AnalystWire
BioMarin Pharmaceutical Inc. $BMRN PT Raised to $98 at RBC Capital https://t.co/sDRiKS3oZD
May 25th 2018, 6:05am
BioBreakout @BioBreakout
$BMRN BioMarin Pharma Receives FDA Approval for Palynziq Injection for Treatment of Adults with Phenylketonuria
May 25th 2018, 5:05am

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.